BBVA
GNMK

Banco Bilbao Vizcaya Argentaria’s GenMark Diagnostics, Inc GNMK Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,000
Closed -$192K – 781
2019
Q4 		$192K Buy
+40,000
New +$221K 0.01% 682

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's GNMK Position: Q1 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 40,000 shares — an estimated $192K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in GNMK in Q4 2019 and held it in 1 quarter. The position peaked at $192K in Q4 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 40,000 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $192K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in GenMark Diagnostics, Inc in Q4 2019 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's GenMark Diagnostics, Inc position peaked at $192K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2020, filed 13 May 2020.